Health care and social assistance: what US businesses sold for

What is my health care and social assistance business worth?

Health care and social assistance businesses in the United States sold for a median of 9.0 times EBITDA (30+ deals of US$10 million to US$500 million, deals announced 2005 to 2023, every year we hold). The middle half of those deals ran from 7.5 to 11.5 times.

Deals updated October 2026

By deal size

Each size band on its own. A band with too few deals shows no figure.

US$10 million to US$500 million
Median 9.0 times EBITDA. The middle half of deals ran from 7.5 to 11.5 times (30+ deals of US$10 million to US$500 million, deals announced 2005 to 2023, every year we hold).
US$500 million to US$2 billion
Median 12.0 times EBITDA. The middle half of deals ran from 10.5 to 15.0 times (10+ deals of US$500 million to US$2 billion, deals announced 2017 to 2022, the last ten years).
All deals
Median 12.0 times EBITDA. The middle half of deals ran from 9.5 to 14.5 times (30+ deals of all sizes, deals announced 2017 to 2024, the last ten years).

Within this industry

Each sub-industry with enough deals, at its own size band.

  • Dental: Median 8.0 times EBITDA (5+ deals of US$10 million to US$500 million, deals announced 2005 to 2019, every year we hold). The group is small, so no middle half is shown.
  • Dialysis and renal care: Median 10.0 times EBITDA (5+ deals under US$2 billion, deals announced 2010 to 2020, every year we hold). The group is small, so no middle half is shown.
  • Home health and hospice: Median 11.5 times EBITDA. The middle half of deals ran from 10.5 to 12.5 times (10+ deals under US$2 billion, deals announced 2010 to 2021, every year we hold).
  • Hospitals and surgery centers: Median 8.5 times EBITDA. The middle half of deals ran from 6.5 to 9.5 times (10+ deals under US$2 billion, deals announced 2009 to 2021, every year we hold).
  • Pharmacy benefit management: Median 13.0 times EBITDA (5+ deals under US$2 billion, deals announced 2011 to 2015, every year we hold). The group is small, so no middle half is shown.
  • Physician practices: Median 13.5 times EBITDA (5+ deals under US$2 billion, deals announced 2005 to 2016, every year we hold). The group is small, so no middle half is shown.
  • Other businesses in this industry: Median 10.0 times EBITDA. The middle half of deals ran from 6.0 to 12.5 times (10+ deals of US$10 million to US$500 million, deals announced 2010 to 2023, every year we hold).

Pick an industry and a size. Enter your yearly earnings to see them at the multiples those businesses sold at. Nothing you enter leaves this page.

This is not a valuation. It is arithmetic on reported deals. A buyer sets the price after testing your earnings, customers and plan.

Health care and social assistance: what buyers paid

In Health care and social assistance, US deals in our database sold at a median of 9.0 times EBITDA. The middle half sold at 7.5 to 11.5 times.

30+ deals, announced 2005 to 2023. Too few recent deals sit in this group, so it covers every year from 2005.

These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.

How these figures are made. Where these deals come from, and what they leave out, is on the method page.

These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.

Built by Andrew Wilson and Claire Grego, former partners of strategy consulting firms. Between them they have worked at Bain, BCG, Monitor Deloitte and Strategy&.